Abstrakt
Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Menopause (New York, N.Y.) |
Vol/bind | 18 |
Udgave nummer | 2 |
Sider (fra-til) | 171-7 |
Antal sider | 7 |
DOI | |
Status | Udgivet - 1 feb. 2011 |